• Crisaborole

    Crisaborole

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Crisaborole Dermatitis ea Atopic le Eczema Pfizer  
  • Etelcacetide

    Etelcacetide

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Etelcacetide Hyperparathyroidism ea bobeli (HPT) Amgen  
  • Abemaciclib

    Abemaciclib

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Abemaciclib Kankere ea matsoele, phekolo ea kankere ea senya Eli Lily Dec.15,2029
  • Deucracitinib

    Deucracitinib

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Deucracitinib Anti plaque psoriasis Khamphani ea Bristol-Myers Squibb Nov.07,2033
  • Apremilast

    Apremilast

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Apremilast ramatiki ea psoriatic Celgene  
  • Remdesivir

    Remdesivir

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Remdesivir Li-antivirus (Ebola, Covid-19) Gileade  

     

  • Paxlovid

    Paxlovid

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Paxlovid Covid 19 Pfizer  

     

  • Pomalidomide

    Pomalidomide

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Pomalidomide Moriana oa Oncology Celgene  

     

  • Nirmatrelvir

    Nirmatrelvir

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Nirmatrelvir 3C-Like Protease (3CLPRO) Inhibitor Le SARS-Cov-2 Mpro Inhibitor    

     

  • Eltrombopag

    Eltrombopag

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Eltrombopag ITP le Aplastic anemia Novartis le GSK Mots'eanong. La 20, 2023
  • Ruxolitinib

    Ruxolitinib

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Ruxolitinib Myelofibrosis Novartis La 6 Phupu 2024
  • Crisaborole

    Crisaborole

    Lebitso la API Pontsho Moqapi Letsatsi la Phello ea Patent(US)
    Crisaborole Dermatitis ea Atopic le Eczema Pfizer La 11 Phuptjane 2026